NCT03071679

Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers

A Randomized, Evaluator-blinded, Vehicle-controlled Study to Explore the Pharmacodynamic Effects of Omiganan and Omiganan in Combination With Imiquimod in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 16 (actual)
• Sponsor: Maruho Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This study has a randomized, evaluator-blinded, vehicle- controlled study to assess the pharmacodynamics of omiganan and omiganan with imiquimod in healthy volunteers.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Omiganan	Omignan 1%, 2.5%
DRUG	Imiquimod	Imiquimod 15mg
DRUG	Omiganan 1% and Imiquimod	Omiganan 1% and Imiquimod
DRUG	Omiganan 2.5% and Imiquimod	Omiganan 2.5% and Imiquimod
DRUG	Placebo	Vehicle

Timeline

• Start date: 2017-02-06
• Primary completion: 2017-03-07
• Completion: 2017-03-07
• First posted: 2017-03-07
• Last updated: 2017-05-22

Locations

1 site across 1 country: Netherlands